A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury

Journal of Immunology

Volumn 174, Issue 8, 2005, Pages 5040-5046

  Day, Yuan Ji ^a   Li, Yuesheng ^b   Rieger, Jayson M ^c   Ramos, Susan I ^a   Okusa, Mark D ^b   Linden, Joel ^a,b,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Adenosine Therapeutics LLC   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [6 AMINO 9 (5 CYCLOPROPYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDROFURAN 2 YL) 9H PURIN 2 YL]PROP 2 YNYL]PIPERIDINE 1 CARBOXYLIC ACID METHYL ESTER; 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDROFURAN 2 YL) 9H PURIN 2 YL]PROP 2 YNYL]CYCLOHEXANECARBOXYLIC ACID; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ALANINE AMINOTRANSFERASE; ATL 313; CYTOKINE; DRUG METABOLITE; FURAN DERIVATIVE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; RANTES; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; PURINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HISTOLOGY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DRUG POTENTIATION; GENETICS; INJURY; LIVER; METABOLISM; MOUSE MUTANT; VASCULARIZATION;

ALANINE TRANSAMINASE; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CHIMERA; CYCLOHEXANECARBOXYLIC ACIDS; CYTOKINES; ENDOTHELIUM, VASCULAR; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PURINES; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY;

EID: 17044426358     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.8.5040     Document Type: Article

References (34)

1. Reshef, A., O. Sperling, and E. Zoref-Shani. 1998. Adenosine-induced preconditioning of rat neuronal cultures against ischemia-reperfusion injury. Adv. Exp. Med. Biol. 431:365.
2. Kurz, M. A., D. A. Bullough, C. J. Bugge, K. M. Mullane, and M. A. Young. 1997. Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine. Eur. J. Pharmacol. 322:211.
3. Day, Y. J., L. Huang, M. J. McDuffie, D. L. Rosin, H. Ye, J. F. Chen, M. A. Schwarzschild, J. S. Fink, J. Linden, and M. D. Okusa. 2003. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112:883.
4. 2a agonist COS-21680 in infarcted and stunned porcine myocardium. Am. J. Physiol. 280:H1660.
5. Peirce, S. M., T. C. Skalak, J. M. Rieger, T. L. MacDonald, and J. Linden. 2001. Selective A2A adenosine receptors activation reduces skin pressure ulcer formation and inflammation. Am. J. Physiol. 281:H67.
6. Ross, S. D., C. G. Tribble, J. Linden, J. J. Gangemi, B. C. Lanpher, A. Y. Wang, and I. L. Kron. 1999. Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J. Heart Lung Transplant. 18:994.
7. 2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann. Thorac. Surg. 72:1245.
8. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in down-regulation of inflammation and protection from tissue damage. Nature 414:916.
9. Day, Y. J., M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden. 2004. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. 286:G285.
10. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19:9192.
11. Charbonneau, H., N. K. Tonks, K. A. Walsh, and E. H. Fischer. 1988. The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 85:7182.
12. Morse, H. C., III. 1992. Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. J. Immunol. 149:3129.
13. Jin, H., R. Zastawny, S. R. George, and B. F. O'Dowd. 1997. Elimination of palmitoylation sites in the human dopamine D1 receptor does not affect receptor-G protein interaction. Eur. J. Pharmacol. 324:109.
14. Sullivan, G. W., G. Fang, J. Linden, and W. M. Scheid. 2004. A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J. Infect. Dis. 189:1897.
15. Auchampach, J. A., J. Jin, T. C. Wan, G. H. Caughey, and J. Linden. 1997. Canine mast cell adenosine receptors: cloning and expression of the A3 receptors and evidence that degranulation is mediated by the A2B receptor. Mol. Pharmacol. 52:846.
16. q in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 56:705.
17. 2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J. Pharmacol. Exp. Ther. 294:1034.
18. Jordan, J. E., Z. Q. Zhao, H. Sato, S. Taft, and J. Vinten-Johansen. 1997. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J. Pharmacol. Exp. Ther. 280:301.
19. Fenster, M. S., R. K. Shepherd, J. Linden, and B. R. Duling. 2000. Activation of adenosine A2 α receptors inhibits mast cell degranulation and mast cell-dependent vasoconstriction. Microcirculation 7:129.
20. Hourani, S. M. 1996. Purinoceptors and platelet aggregation. J. Auton. Pharmacol. 16:349.
21. Day, Y. J., L. Huang, H. Ye, J. Linden, and M. D. Okusa. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of macrophages. Am. J. Physiol. In press.
22. Dickenson, J. M., S. Reeder, B. Rees, S. Alexander, and D. Kendall. 2003. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106. Eur. J. Pharmacol. 474:43.
23. + T cells. J. Immunol. 174:1073.
24. 2a receptor-dependent and independent mechanisms. FASEB J. 14:2065.
25. Panther, E., M. Idzko, Y. Herouy, H. Rheinen, P. J. Gebicke-Haerter, U. Mrowietz, S. Dichmann, and J. Norgauer. 2001. Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15:1963.
26. Le Moine, O., H. Louis, A. Demols, F. Desalle, F. Demoor, E. Quertinmont, M. Goldman, and J. Deviere. 2000. Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 31:1266.
27. Lentsch, A. B., H. Yoshidome, W. G. Cheadle, F. N. Miller, and M. J. Edwards. 1998. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 27:507.
28. Orlic, D., J. Kajstura, S. Chimenti, I. Jakoniuk, S. M. Anderson, B. Li, J. Pickel, R. McKay, B. Nadal-Ginard, D. M. Bodine, A. Leri, and P. Anversa. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410:701.
29. Ferrari, G., A. G. Cusella-De, M. Coletta, E. Paolucci, A. Stomaiuolo, G. Cossu, and F. Mavilio. 1998- Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528.
30. Gussoni, E., Y. Soneoka, C. D. Strickland, E. A. Buzney, M. K. Khan, A. F. Flint, L. M. Kunkel, and R. C. Mulligan. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390.
31. Asahara, T., H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver, M. Kearne, M, Magner, and J. M. Isner. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85:221.
32. Rookmaaker, M. B., H. Tolboom, R. Goldschmeding, J. J. Zwaginga, T. J. Rabelink, and M. C. Verhaar. 2002. Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood 99:1095.
33. Sata, M., A. Saiura, A. Kunisato, A. Tojo, S. Okada, T. Tokuhisa, H. Hirai, M. Makuuchi, Y. Hirata, and R. Nagai. 2002. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8:403.
34. 4. Mol. Pharmacol. 61:455.